Fluorescent homooxacalixarenes: recent applications in supramolecular systems

This review covers recent advances (from 2006 to date) in supramolecular systems based on fluorescent homooxacalixarenes, namely hexahomotrioxacalix[3]arenes, dihomooxacalix[4]arenes and tetrahomodioxacalix[4]arenes, focusing on fluorescence sensing using their intrinsic fluorescence (built-in mesitol-like groups) or the extrinsic fluorescence of organic fluorophores, either covalently linked to the calixarenes or forming supramolecular complexes with them. Sensing applications of ions, ion pairs and neutral molecules are discussed, as well as the potential measurement of temperature based on thermally activated delayed fluorescence.

Intermolecular hydrogen bonding of alcohols with dinitrobenzene radical anion and dianion: A combined electrochemical and DFT study

Hydrogen bonding is one of the most important inter-molecular interactions in the field of biochemistry and medicinal chemistry. Such non-covalent interactions play a vital role in self-assembly phenomena, chemical structures, material properties and enzymatic catalysis. Herein, we present hydrogen bonding phenomenon in alcohols-dinitrobenzene (DNB) radical anion/dianion systems using electrochemical and computational approaches. First, 1,3-DNB radical anion and dianion were generated through electrochemical method and then hydrogen bonding interactions with aliphatic alcohols in DMSO are studied through cyclic voltammetry (CV). CV results show that the cathodic peak potential of 1,3-Dinitrobenzene in Dimethyl sulfoxide is shifted catholically upon addition of alcohols which represent hydrogen bonding phenomenon. Theoretical investigations are performed to gain deep insight on hydrogen bonding interaction strength in DNB-alcohol systems. H-bonding interaction of all isomers of DNB (1,2-, 1,3-, 1,4-), its corresponding radical anion, and dianion with aliphatic alcohols is studied using density functional calculations. The strength of H-bonding is evaluated both qualitatively and quantitatively using interaction energies, vibrational and electronic spectroscopic analysis. Understanding of these interactions will be helpful in gaining insight into biological systems where these interactions play significant role.

A p-tert-Tutyldihomooxacalix[4]arene Based Soft Gel for Sustained Drug Release in Water

P-tert-butyldihomooxacalix[4]arene is a well-known calix[4]arene analog in which one CH₂ bridge is replaced by one -O- group. Thus, dihomooxacalix[4]arene has a slightly larger cavity than that of calix[4]arene and usually possesses a more flexible cone conformation, and the bridged oxygen atom might provide additional binding sites. Here, we synthesized a new functional p-tert-butyldihomooxacalix[4]arene 1 through Ugi reaction with good yield (70%), starting from condensed p-tert-butyldihomooxacalix[4]arene O-alkoxy-substituted benzaldehydes, benzoic acid, benzylamine, and cyclohexyl isocyanide. Proton nuclear magnetic resonance spectroscopy (¹H NMR), ¹³C NMR, IR, and diffusion-ordered ¹H NMR spectroscopy (DOSY) methods were used to characterize the structure of 1. Then soft gel was prepared by adding 1 into cyclohexane directly. It shows remarkable thermoreversibility and can be demonstrated for several cycles. As is revealed by scanning electron microscopy (SEM) images, xerogel showed highly interconnected and homogeneous porous network structures, and hence, the gel is suitable for storage and controlled release.

Structural Design, Synthesis, and Preliminary Biological Evaluation of Novel Dihomooxacalix[4]arene-Based Anti-tumor Agents

Calixarene and its derivatives have extensively served as promising anti-tumor agents. Previously, we have synthesized a series of calix[n]arene polyhydroxyamine derivatives (n = 4, 6, 8) and found that 5,11,17,23-tetra-tert-butyl-25,27-bis [N-(2-hydroxyethyl)aminocarbonylmethoxyl] calix[4]arene (CLX-4) displayed significant effect toward SKOV3, A549, SW1990, HeLa, Raji, and MDA-MB-231 cancer cells. In the present work, we find a replacement of calix[4]arene bone and synthesized 19 novel structurally related dihomooxacalix[4]arene amide derivatives 4A-4S to optimize its efficacy. Their abilities to induce cytotoxicity in human lung carcinoma (A549) cells, breast cancer (MCF-7) cells, cervical cancer (HeLa) cells, hepatocellular carcinoma (HepG2) cells, as well as human umbilical vein endothelial (HUVEC) cells are evaluated in vitro. Encouraging results show that the majority of dihomooxacalix[4]arene amide derivatives are effective at inhibiting A549 cell proliferation with the corresponding IC₅₀ ranging from 0.6 to 20.1 μM. In particular, compounds 4A, 4D, and 4L explore markedly increased potency (IC₅₀ value is 2.0 ± 0.5 μM, 0.7 ± 0.1 μM, and 1.7 ± 0.4 μM) over the cytotoxicity profiles of control CLX-4, whose IC₅₀ value is 2.8 ± 0.3 μM. More interestingly, 4A also demonstrates the perfect cytotoxic effect against MCF-7, HeLa, and HepG2 cells with IC₅₀ values of 1.0 ± 0.1 μM, 0.8 ± 0.2 μM, and 2.7 ± 0.4 μM. In addition, the results proved that our synthesized 4A has much lower toxicity (41%) to normal cells at a concentration of 10 μM than that of 4D (90%). To reveal the mechanisms, the key indicators including the cell cycle and apoptosis are observed by the flow cytometry analysis in MCF-7 cells. The results demonstrate that both 4A and 4D can induce the MCF-7 cell cycle arrest in G0/G1 phase and cell apoptosis. Therefore, our finding proves that the dihomooxacalix[4]arene amide derivatives are convenient platforms for potential supramolecular anticancer agents.

Multi-point interaction-based recognition of fluoride ions by tert-butyldihomooxacalix[4]arenes bearing phenolic hydroxyls and thiourea

A series of p-tert-butyldihomooxacalix[4]arenes bearing phenolic hydroxyls and thiourea moieties were prepared to investigate their anion binding behavior.

Preparation andin vitrobioactivity evaluation of N-heterocyclic-linked dihomooxacalix[4]arene derivatives

Based on the superior prospects of calixarenes-based agents and N-heterocyclic pharmacophores in biomedical applications, 14 new dihomooxacalix[4]arene N-heterocyclic (pyridine, quinoline, and thiazole) derivatives 4a–4n were efficiently synthesized from the parent compound, namely, p-tert-butyldihomooxacalix[4]arene 1; they were further investigated by using their IR, ¹H NMR, ¹³C NMR, and HRMS spectra. Among these derivatives, the crystal and molecular structures of 2-aminomethyl-pyridine-substituted dihomooxacalix[4]arene 4f (obtained from methanol) have been determined by X-ray diffraction. In the case of the inhibition assay of cell growth, we evaluated the effects on four select tumor cell lines (MCF-7, HepG2, SKOV3, and HeLa), as well as the normal cell lines of HUVEC, using paclitaxel as the positive control drug. It was found that the derivatives 4d–4f, 4i, 4k, and 4l could inhibit tumoral activity up to varying degrees. Mechanistically, the cell cycle analysis demonstrated that dihomooxacalix[4]arene N-heterocyclic derivatives could induce apoptosis of MCF cells. In addition, the results of the western blot and immunofluorescence studies revealed the upregulation of the protein expression levels of Bax and cleaved caspase-3, as well as the downregulation of Bcl-2, which are in good agreement with the corresponding inhibitory potencies. Therefore, these findings suggest that N-heterocyclic derivatives based on the dihomooxacalix[4]arene scaffold are promising candidates for use against cancer.

Based on superior prospects of calixarenes in biomedical fields, the bioactivity of novel N-heterocyclic linked dihomooxacalix[4]arene derivatives 4a–4n were evaluated in vitro. The crystal structure of 4f was also determined by X-ray diffraction.